NASDAQ : QURE
uniQure N.V. — Financial statements
Healthcare · Biotechnology · Netherlands
Last price 24.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.72B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
uniQure N.V. (QURE) reported revenue of 18.67M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 18.67M | 16.10M | 27.12M | 15.84M | 106.48M | 524.00M |
| Cost of Revenue | 133.38M | 136.11M | 159.96M | 208.97M | 192.12M | 161.84M |
| Gross Profit | -114.71M | -120.01M | -132.84M | -193.13M | -85.64M | 362.16M |
| Selling, General & Admin | 76.10M | 65.46M | 51.43M | 74.23M | 55.06M | 56.29M |
| Other Operating Expenses | 6.57M | -6.37M | -2.20M | -5.16M | -6.05M | -5.83M |
| Operating Expenses | 82.67M | 59.09M | 49.23M | 69.07M | 49.01M | 50.46M |
| Operating Income | -197.38M | -179.10M | -182.07M | -262.20M | -134.65M | 311.70M |
| Interest Expense | -59.69M | -61.99M | -63.74M | -41.56M | -11.70M | -7.47M |
| Interest & Investment Income | 19.60M | 16.97M | 21.41M | 19.56M | 609.00K | 162.00K |
| Currency Exchange Gain (Loss) | -3.70M | 26.13M | -10.51M | -1.69M | 23.23M | 29.66M |
| Other Non Operating Income (Expenses) | -1.30M | 10.90M | 2.76M | -160.00K | ||
| EBT Excluding Unusual Items | -242.47M | -187.09M | -234.90M | -285.88M | -119.75M | 333.89M |
| Merger & Restructuring Charges | -5.19M | -2.55M | ||||
| Gain (Loss) on Sale of Investments | -790.00K | 300.00K | 3.00M | |||
| Gain (Loss) on Sale of Assets | 1.15M | |||||
| Asset Writedown | -1.44M | |||||
| Other Unusual Items | -2.69M | -6.25M | 1.82M | -15.89M | -8.81M | -4.08M |
| Pretax Income | -245.17M | -193.34M | -237.13M | -306.56M | -128.26M | 332.81M |
| Income Tax Expense | 7.04M | 5.63M | 2.43M | 1.92M | -1.47M | 3.22M |
| Net Income | -252.21M | -198.97M | -239.56M | -308.48M | -126.79M | 329.59M |
| Net Income to Common | -252.21M | -198.97M | -239.56M | -308.48M | -126.79M | 329.59M |
| Shares Outstanding (Basic) | 62.48M | 57.50M | 48.65M | 47.67M | 46.74M | 45.99M |
| Shares Outstanding (Diluted) | 62.48M | 57.50M | 48.65M | 47.67M | 46.74M | 46.84M |
| EPS (Basic) | -4.04 | -3.46 | -4.92 | -6.47 | -2.71 | 7.17 |
| EPS (Diluted) | -4.04 | -3.46 | -4.92 | -6.47 | -2.71 | 7.04 |
| Free Cash Flow | -161.45M | -178.40M | -186.10M | -153.08M | -162.75M | 270.52M |
| Free Cash Flow Per Share | -2.58 | -3.10 | -3.83 | -3.21 | -3.48 | 5.78 |
| Gross Margin | -80.42% | 69.11% | ||||
| Operating Margin | -1,057.10% | -1,112.57% | -671.38% | -1,654.98% | -126.45% | 59.48% |
| Profit Margin | -1,350.73% | -1,236.00% | -883.35% | -1,947.09% | -119.07% | 62.90% |
| Free Cash Flow Margin | -864.67% | -1,108.22% | -686.22% | -966.25% | -152.84% | 51.63% |
| EBITDA | -182.92M | -164.34M | -169.43M | -250.30M | -126.11M | 319.00M |
| EBITDA Margin | -118.43% | 60.88% | ||||
| D&A For EBITDA | 14.46M | 14.76M | 12.64M | 11.90M | 8.54M | 7.30M |
| EBIT | -197.38M | -179.10M | -182.07M | -262.20M | -134.65M | 311.70M |
| EBIT Margin | -126.45% | 59.48% | ||||
| Effective Tax Rate | 0.97% | |||||
| Revenue as Reported | 18.67M | 16.10M | 27.12M | 15.84M | 106.48M | 524.00M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 413.03M | 80.24M | 158.93M | 241.36M | 228.01M | 556.26M |
| Short-Term Investments | 397.31M | 542.30M | 208.59M | 376.53M | 124.83M | |
| Cash & Short-Term Investments | 810.34M | 622.54M | 367.52M | 617.89M | 352.84M | 556.26M |
| Receivables | 5.78M | 5.86M | 5.88M | 4.19M | 102.38M | 58.77M |
| Inventory | 12.02M | 6.92M | ||||
| Prepaid Expenses | 10.24M | 20.51M | 9.28M | 15.09M | 11.82M | 10.54M |
| Other Current Assets | 7.91M | 7.08M | 7.61M | 2.65M | 2.81M | 2.67M |
| Total Current Assets | 834.27M | 655.99M | 390.29M | 651.85M | 476.77M | 628.24M |
| Property, Plant & Equipment | 22.98M | 26.32M | 34.07M | 75.34M | 83.26M | 69.08M |
| Long-Term Investments | 30.27M | 30.24M | 27.46M | 2.18M | 39.98M | |
| Goodwill | 24.59M | 25.36M | 22.41M | 26.38M | 25.58M | 27.63M |
| Other Intangible Assets | 62.10M | 72.79M | 71.04M | 60.48M | 58.78M | 62.69M |
| Long-Term Deferred Tax Assets | 6.36M | 8.65M | 9.86M | 12.28M | 14.53M | 15.65M |
| Other Long-Term Assets | 4.54M | 5.56M | 1.40M | 3.18M | 6.06M | 5.90M |
| Total Assets | 985.10M | 824.91M | 556.54M | 831.69M | 704.96M | 809.18M |
| Accounts Payable | 4.98M | 5.17M | 7.23M | 6.59M | 10.98M | 2.50M |
| Accrued Expenses | 41.34M | 30.43M | 22.40M | 29.10M | 28.32M | 25.61M |
| Current Portion of Leases | 2.99M | 3.86M | 3.60M | 8.34M | 8.38M | 5.77M |
| Other Current Liabilities | 34.04M | 23.46M | 6.83M | 29.65M | 28.23M | 2.87M |
| Total Current Liabilities | 83.34M | 62.92M | 40.05M | 73.67M | 75.92M | 36.76M |
| Long-Term Debt | 539.48M | 522.90M | 486.25M | 495.99M | 102.79M | 100.96M |
| Long-Term Leases | 9.70M | 9.83M | 11.14M | 28.32M | 31.72M | 28.99M |
| Long-Term Deferred Tax Liabilities | 7.73M | 7.97M | 7.04M | 7.54M | 8.26M | 12.91M |
| Other Long-Term Liabilities | 20.81M | 22.39M | 18.80M | 18.50M | 10.27M | 33.78M |
| Total Liabilities | 661.05M | 626.01M | 563.29M | 624.02M | 228.96M | 213.40M |
| Common Stock | 4.09M | 3.69M | 2.94M | 2.88M | 2.84M | 2.80M |
| Additional Paid-In Capital | 1.84B | 1.58B | 1.17B | 1.15B | 1.11B | 1.08B |
| Retained Earnings | -1.46B | -1.33B | -1.13B | -890.41M | -581.93M | -455.14M |
| Comprehensive Income & Other | -58.25M | -58.22M | -52.80M | -53.55M | -58.29M | -28.86M |
| Shareholders' Equity | 324.05M | 198.90M | -6.75M | 207.67M | 476.01M | 595.78M |
| Total Liabilities & Equity | 985.10M | 824.91M | 556.54M | 831.69M | 704.96M | 809.18M |
| Total Debt | 552.17M | 536.59M | 500.99M | 532.65M | 142.89M | 135.72M |
| Net Cash (Debt) | 258.17M | 85.95M | -133.47M | 85.24M | 209.95M | 420.53M |
| Net Cash Per Share | 4.13 | 1.49 | -2.74 | 1.79 | 4.49 | 8.98 |
| Filing Date Shares Outstanding | 69.37M | 62.53M | 54.08M | 47.84M | 46.98M | 46.46M |
| Total Common Shares Outstanding | 69.33M | 62.34M | 48.99M | 47.83M | 46.97M | 46.30M |
| Working Capital | 750.92M | 593.07M | 350.24M | 578.18M | 400.86M | 591.48M |
| Book Value Per Share | 4.67 | 3.19 | -0.14 | 4.34 | 10.13 | 12.87 |
| Tangible Book Value | 237.36M | 100.76M | -100.21M | 120.81M | 391.65M | 505.46M |
| Tangible Book Value Per Share | 3.42 | 1.62 | -2.05 | 2.53 | 8.34 | 10.92 |
| Machinery | 29.35M | 27.27M | 50.04M | 44.38M | 29.96M | |
| Construction In Progress | 5.67M | 5.41M | 5.07M | |||
| Leasehold Improvements | 28.19M | 24.81M | 46.51M | 44.87M | 45.37M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -252.21M | -198.97M | -239.56M | -308.48M | -126.79M | 329.59M |
| Depreciation & Amortization | 14.46M | 14.76M | 12.64M | 11.90M | 8.54M | 7.30M |
| Loss (Gain) From Sale of Investments | -14.21M | -10.46M | -10.90M | -10.92M | ||
| Stock-Based Compensation | 18.29M | 17.68M | 22.26M | 35.09M | 34.20M | 25.64M |
| Other Operating Activities | 47.35M | 5.82M | 36.77M | 44.03M | -17.63M | -24.08M |
| Change in Accounts Receivable | 7.01M | -8.60M | -2.24M | 98.68M | -49.08M | -58.96M |
| Change in Inventory | 2.42M | -6.74M | -6.92M | |||
| Change in Accounts Payable | -302.00K | -2.67M | 1.52M | -4.17M | 9.24M | -727.00K |
| Change in Other Net Operating Assets | 18.81M | 4.47M | -5.64M | -5.33M | 3.38M | 9.20M |
| Operating Cash Flow | -160.79M | -177.96M | -182.73M | -145.93M | -145.06M | 287.96M |
| Capital Expenditures | -665.00K | -439.00K | -3.37M | -7.15M | -17.69M | -17.44M |
| Cash Acquisitions | -1.90M | -49.95M | ||||
| Divestitures | -8.32M | |||||
| Investment in Securities | -262.31M | -321.18M | 174.66M | -198.53M | -163.15M | |
| Investing Cash Flow | -262.97M | -321.62M | 162.97M | -205.69M | -182.73M | -67.39M |
| Long-Term Debt Issued | 370.06M | 64.07M | ||||
| Long-Term Debt Repaid | -53.05M | -1.57M | ||||
| Net Debt Issued (Repaid) | -53.05M | 370.06M | 62.49M | |||
| Issuance of Common Stock | 560.85M | 391.90M | 2.12M | 308.00K | 1.45M | 33.70M |
| Other Financing Activities | 23.50M | 23.50M | -8.56M | -7.65M | -1.33M | |
| Financing Cash Flow | 584.35M | 415.40M | -59.49M | 362.72M | 1.45M | 94.86M |
| Foreign Exchange Rate Adjustments | -1.30M | 5.66M | -4.97M | 2.27M | -1.83M | -3.76M |
| Net Cash Flow | 159.29M | -78.53M | -84.22M | 13.37M | -328.18M | 311.67M |
| Free Cash Flow | -161.45M | -178.40M | -186.10M | -153.08M | -162.75M | 270.52M |
| Free Cash Flow Margin | -864.67% | -1,108.22% | -686.22% | -966.25% | -152.84% | 51.63% |
| Free Cash Flow Per Share | -2.58 | -3.10 | -3.83 | -3.21 | -3.48 | 5.78 |
| Levered Free Cash Flow | -77.58M | -106.76M | -139.79M | -62.24M | -81.82M | 156.81M |
| Unlevered Free Cash Flow | -40.27M | -68.01M | -99.95M | -36.27M | -74.50M | 161.48M |
| Cash Interest Paid | 26.91M | 25.07M | 20.57M | 16.88M | 9.25M | 6.54M |
| Change in Working Capital | 25.52M | -6.79M | -3.94M | 82.44M | -43.38M | -50.48M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.59B | 1.49B | 860.80M | 323.68M | 1.06B | 958.48M |
| Enterprise Value | 1.34B | 1.33B | 919.85M | 186.77M | 759.71M | 487.04M |
| Last Close Price | 24.83 | 23.93 | 17.66 | 6.77 | 22.67 | 20.74 |
| PE Ratio | 2.91 | |||||
| Forward PE | 27.23 | 27.23 | 27.23 | 27.23 | 27.23 | |
| PS Ratio | 86.19 | 92.60 | 31.74 | 20.43 | 9.97 | 1.83 |
| PB Ratio | 5.31 | 7.49 | -127.49 | 1.56 | 2.23 | 1.61 |
| P/TBV Ratio | 6.78 | 14.79 | 2.68 | 2.71 | 1.90 | |
| P/FCF Ratio | 3.54 | |||||
| P/OCF Ratio | 3.33 | |||||
| EV/Sales Ratio | 72.36 | 82.50 | 33.92 | 11.79 | 7.13 | 0.93 |
| EV/EBITDA Ratio | 1.53 | |||||
| EV/EBIT Ratio | 1.56 | |||||
| EV/FCF Ratio | 1.80 | |||||
| Debt / Equity Ratio | 1.70 | 2.70 | -74.20 | 2.56 | 0.30 | 0.23 |
| Debt / EBITDA Ratio | 0.42 | |||||
| Debt / FCF Ratio | 0.50 | |||||
| Net Debt / Equity Ratio | -0.80 | -0.43 | -19.77 | -0.41 | -0.44 | -0.71 |
| Net Debt / EBITDA Ratio | 1.41 | 0.52 | -0.79 | 0.34 | 1.67 | -1.32 |
| Net Debt / FCF Ratio | 1.60 | 0.48 | -0.72 | 0.56 | 1.29 | -1.55 |
| Asset Turnover | 0.02 | 0.02 | 0.04 | 0.02 | 0.14 | 0.91 |
| Inventory Turnover | 22.06 | |||||
| Quick Ratio | 9.79 | 9.99 | 9.32 | 8.44 | 6.00 | 16.73 |
| Current Ratio | 10.01 | 10.43 | 9.74 | 8.85 | 6.28 | 17.09 |
| Return on Equity (ROE) | -157.61% | -207.10% | -238.46% | -90.24% | -23.66% | 78.50% |
| Return on Assets (ROA) | -15.72% | -16.21% | -16.39% | -21.33% | -11.12% | 33.89% |
| Return on Invested Capital (ROIC) | -226.44% | -56.91% | -56.99% | -134.99% | -61.02% | 251.21% |
| Return on Capital Employed (ROCE) | -21.90% | -23.50% | -35.30% | -34.60% | -21.40% | 40.40% |
| Earnings Yield | -17.57% | -13.35% | -27.83% | -95.30% | -11.95% | 34.39% |
| FCF Yield | -10.03% | -11.97% | -21.62% | -47.30% | -15.33% | 28.22% |
| Buyback Yield / Dilution | -20.93% | -18.20% | -2.05% | -2.00% | 0.23% | -5.34% |